| PERIOD ENDING | 31-Jan-05 | 31-Jan-04 | 31-Jan-03 | | Total Revenue | 423,911 | 384,535 | 246,588 | | Cost of Revenue | 358,501 | 322,650 | 211,533 | | | Gross Profit | 65,410 | 61,885 | 35,055 | | | Operating Expenses | | Research Development | 40,578 | 50,034 | 34,568 | | Selling General and Administrative | 53,491 | 60,039 | 42,393 | | Non Recurring | 61,512 | 7,192 | 4,228 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (90,171) | (55,380) | (46,134) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (93) | 5,698 | 905 | | Earnings Before Interest And Taxes | (90,264) | (49,682) | (45,229) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (90,264) | (49,682) | (45,229) | | Income Tax Expense | (62) | (274) | 18,565 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (90,202) | (49,408) | (63,794) | | | Non-recurring Events | | Discontinued Operations | (579) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (90,781) | (49,408) | (63,794) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($90,781) | ($49,408) | ($63,794) |
|
1.48% Nasdaq 
Income Statement
